When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MBIO - Mustang Bio up 8% premarket on accelerated review status for MB-107 in Europe
Mustang Bio Inc.
The European Medicines Agency (EMA) has granted Advanced Therapy Medicinal Product (ATMP) classification to Mustang Bio's (NASDAQ:MBIO) MB-107, a lentiviral gene therapy for the treatment of X-linked severe combined immunodeficiency, also known as bubble boy disease.
More news on: Mustang Bio, Inc., Healthcare stocks news, Stocks on the move,